A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 66, Issue 1-2, 1996, Pages 49-55

  Van Oosten, B W ^a   Rep, M H G ^b   Van Lier, R A W ^b   Scholten, P E T ^a   Von Blomberg, B M E ^a   Pflughaupt, K W ^c   Hartung, H P ^c   Ader H J ^d   Polman, C H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

multiple sclerosis; pentoxifylline; treatment; tumor necrosis factor alpha

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; PENTOXIFYLLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HELPER CELL; HUMAN; MALE; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0029899905     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(96)00019-7     Document Type: Article

References (55)

1. Baker, D., Butler, D., Scallon, B.J., O'Neill, J.K., Turk, J.L. and Feldmann, M. (1994) Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24, 2040-2048.
2. Baron, J.L., Madri, J.A., Ruddle, N.H., Hashim, G. and Janeway, Jr., C.A. (1993) Surface expression of alpha4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177, 57-68.
3. Barten, D.M. and Ruddle, N.H. (1994) Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 51, 123-133.
4. Beck, J., Rondot, P., Catinot, L., Falcoff, E., Kirchner, H. and Wietzerbin, J. (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? Acta Neurol. Scand. 78, 318-323.
5. Bloemena, E., Roos, M.T.L., Van Heijst, J.L.A.M., Vossen, J.M.J.J. and Schellekens, P.T.A. (1989) Whole-blood lymphocyte cultures. J. Immunol. Methods 122, 161-167.
6. Cannella, B. and Raine, C.S. (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37, 424-435.
7. Chofflon, M., Juillard, C., Juillard, P., Gauthier, G. and Grau G.E. (1992) Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. Eur. Cytokine Netw. 3, 523-531.
8. Doherty, G.M., Jensen, J.C., Alexander, H.R., Buresh, C.M. and Norton, J.A. (1991) Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110, 192-198.
9. De Fougerolles, A.R., Qin, X. and Springer, T.A. (1994) Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-I and ICAM-2 in immune responses. J. Exp. Med. 179, 619-629.
10. Franciotta, D.M., Grimaldi, L.M.E., Martino, G.V., Piccolo, G., Bergamaschi, R., Citterio, A. and Melzi d'Eril, G.V. (1989) Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis. Ann. Neurol. 26, 787-789.
11. Frohman, E.M., Frohman, T.C., Dustin, M.L., Vayuvegula, B., Choi, B., Gupta, A., Van den Noort, S. and Gupta, S. (1989) The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation. J. Neuroimmunol. 23, 117-124.
12. Gallo, P., Piccino, M.G., Krzalic, L. and Tavolato, B. (1989) Tumor necrosis factor alpha (TNF-alpha) and neurological diseases. Failure in detecting TNF-alpha in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours. J. Neuroimmunol. 23, 41-44.
13. Genain, C.P., Roberts, T., Davis, R.L., Nguyen, M.-H., Uccelli, A., Faulds, D., Li, Y., Hedgpeth, J. and Hauser, S.L. (1995) Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA 92, 3601-3605.
14. Gillis, S., Ferm, M.M., Qu, W. and Smith, K.A. (1978) T-cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120, 2027.
15. De Groote, D., Zangerle, P.F., Gevaert, Y., Fassotte, M.F., Beguin, Y., Noizat-Pirenne, F., Pircnne, J., Gathy, R., Lopez, M., Dehart, I., Igot, D., Baudrihaye, M., Delacroix, D. and Franchimont, P. (1992) Direct stimulation of cytokines (IL-1-beta, TNF-alpha, IL-6, IL-2, IFN-gamma, and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 4, 239-249.
16. Hartung, H.-P., Michels, M., Reiners, K., Seeldrayers, P., Archelos, J.J. and Toyka, K.V. (1993) Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis. Neurology 43, 2331-2335.
17. Hartung, H.-P., Reiners, K., Archelos, J.J., Michels, M., Seeldrayers, P., Heidenreich, F., Pflughaupt, K.W. and Toyka, K.V. (1995) Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann. Neurol. 38, 186-193.
18. Hauser, S.L., Doolittle, T.H., Lincoln, R., Brown, R.H. and Dinarello, C.A. (1990) Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40, 1735-1739.
19. Héry, C., Sébire, G., Peudenier, S. and Tardieu, M. (1995) Adhesion to human neurons and astrocytes of monocytes: the role of interaction of CR3 and ICAM-1 and modulation by cytokines. J. Neuroimmunol. 57, 101-109.
20. Hintzen, R.Q., van Lier, R.A.W., Kuijpers, K.C., Baars, P.A., Schaasberg, W., Lucas, C.J. and Polman, C.H. (1991) Elevated levels of a soluble form of the T-cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 35, 211-217.
21. Imamura, K., Suzumura, A., Hayashi, F. and Marunouchi, T. (1993) Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients. Acta Neurol. Scand. 87, 281-285.
22. Jander, S., Heidenreich, F. and Stoll, G. (1993) Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases. Neurology 43, 1809-1813.
23. Van Kemenade, F.J., Tellegen, E., Maurice, M.M., Lankester, A.C., Kuijpers, T.W., Brouwer, M., de Jong, R., Miedema, F. and Van Lier, R.A.W. (1994) Simultaneous regulation of CD2 adhesion and signalling functions by a novel CD2 monoclonal antibody. J. Immunol. 152, 4425-4432.
24. Kuroda, Y. and Shimamoto, Y. (1991) Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 34, 159-164.
25. Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452.
26. Maksymowych, W.P., Avina-Zubieta, A., Luong, M.H. and Russell, A.S. (1995) An open study of pentoxifyline in the treatment of severe refractory rheumatoid arthritis. J. Rheumatol. 22, 625-629.
27. Martin, S., Rieckmann, P., Melchers, I., Wagner, R., Bertrams, J., Voskuyl, A.E., Roep, B.O., Zielasek, J., Heidenthal, F., Weichselbraun, I., Michael Gallatin, W. and Kolb, H. (1995) Circulating forms of ICAM-3 (cICAM-3). Elevated levels in autoimmune disease and lack of association with cICAM-1. J. Immunol. 154, 1951-1955.
28. Matsuda, M., Tsukada, N., Miyagi, K. and Yanagisawa, N. (1994) Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy. J. Neuroimmunol. 52, 33-40.
29. Monastra, G., Cross, A.H., Bruni, A. and Raine, C.S. (1994) Phosphatidylserine, a putative inhibitor of tumor necrosis factor, prevents autoimmune demyelination. Neurology 43, 153-163.
30. Myers, L.W., Ellison, G.W., Merrill, J.E., Leake, B.D., ElHajjar, A., St. Pierre, B., Granger, D., Fahey, J., Bentson, J. and Tourtelotte, W. (1995) Pentoxifylline not a promising treatment for multiple sclerosis. Neurology 45, 419.
31. Nataf, S., Louboutin, J.P., Chabannes, D., Fève, J.R. and Muller, J.Y. (1993) Pentoxifylline inhibits experimental allergic encephalomyelitis. Acta Neurol. Scand. 88, 97-99.
32. Novick, Jr., W.J., Sullivan, G. and Mandell, G.L. (1990) Newer pharmacologic effects of pentoxifylline. Biorheology 24, 449-454.
33. Peter. J.B., Boctor, F.N. and Tourtelotte, W.W. (1991) Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1β in chronic progressive multiple sclerosis: Expected lack of clinical utility. Neurology 41, 121-123.
34. Poser, C.M., Paty, D.W., Scheinberg, L., et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231.
35. Rep, M.H.G., Hintzen, R.Q., Polman, C.H. and Van Lier, R.A.W. (1994) Functional defects in peripheral blood T cells of multiple sclerosis patients. Diminished in vitro responsiveness in accessory cell dependent activation systems. J. Neuroimmunol. 52, 139-146.
36. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W. and Poser, S. (1994a) Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 44, 1523-1526.
37. Rieckmann, P., Martin, S., Weichselbraun, I., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W., Helwig, A. and Poser, S. (1994b) Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse. Neurology 44, 2367-2372.
38. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W., Helwig, A. and Poser, S. (1995) Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37, 82-88.
39. Robbins, D.S., Shirazi, Y., Drysdale, B.E., Lieberman, A., Shin, H.S. and Shin, M.L. (1987) Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol. 139, 2593-2600.
40. Rott, O., Cash, E. and Fleischer, B. (1993) Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immunol. 23, 1745-1751.
41. Ruddle, N.H., Bergman, C.M., McGrath, K.M., Lingenheld, E.G., Grunnet, M.L., Padula, S.J. and Clark, R.B. (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172, 1193-1200.
42. Satoh, J.I., Kastrukoff, L.F. and Kim, S.U. (1991) Cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) in cultured human oligodendrocytes and astrocytes. J. Neuropathol. Exp. Neurol. 50, 215-226.
43. Selmaj, K. and Raine, C.S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346.
44. Selmaj, K., Raine, C.S., Cannella, B. and Brosnan, C.F. (1991a) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
45. Selmaj, K., Raine, C.S. and Cross, A.H. (1991b) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30, 694-700.
46. Sharief, M.K. and Hentges, R. (1991) Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325, 467-472.
47. Sharief, M.K., Noori, M.A., Ciardi, M., Cirelli, A. and Thompson, E.J. (1993) Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J. Neuroimmunol. 43, 15-22.
48. Sobel, R.A., Mitchell, M.E. and Fondren, G. (1990) Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 136, 1309-1316.
49. Strieter, R.M., Remick, D.G., Ward, P.A., Sprengler, R.N., Lynch III, J.P., Larrick, J. and Kunkel, S.L. (1988) Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem. Biophys. Res. Commun. 155, 1230-1236.
50. Tabata, S., Shimura, T. and Hayashi, S. (1990) Pharmacokinetics of pentoxifylline in neonatal rats in relation to its pharmacological effect. J. Biopharm. Sc. 1, 47-58.
51. Tsukada, N., Miyagi, K., Matsuda, M., Yanagisawa, N. and Yone, K. (1991) Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J. Neurol. Sci. 102, 230-234.
52. Tsukada, N., Matsuda, M., Miyagi, K. and Yanagisawa, N. (1993) Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurology 43, 2679-2682.
53. Ward, A. and Clissold, S.P. (1987) Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34, 83-85.
54. Washington, R., Burton, J., Todd III, R.F., Newman, W., Dragovic, L. and Dore-Duffy, P. (1994) Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels of patients with multiple sclerosis. Ann. Neurol. 35, 89-97.
55. Wong, D. and Dorovini-Zis, K. (1992) Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J. Neuroimmunol. 39, 11-22.